Target intelligence / Profile preview

HIV-1 Rev response element stem-loop IIB (RRE SLIIB)

Target
RRE SLIIB
Molecular classification
Viral RNA, Cis-acting regulatory element, Other
01

Overview

The Rev response element stem-loop IIB (RRE SLIIB) is a highly structured RNA motif within the HIV-1 genome that serves as the primary high-affinity binding site for the viral Rev protein (NIH, 2015; Wikipedia). This interaction is essential for the nuclear export of unspliced and singly spliced viral mRNA transcripts, which are otherwise retained in the nucleus and degraded or over-spliced (NIH, 2015; ASM, 2014). By binding to RRE SLIIB, Rev initiates the assembly of a multimeric complex that recruits host export factors like CRM1 and RanGTP to transport the viral RNA to the cytoplasm for translation and virion assembly (MDPI, 2015; eLife, 2014). Because this pathway is critical for the production of viral structural proteins and the packaging of the viral genome, RRE SLIIB is a significant therapeutic target (NIH, 2015; Duke University, 2024). Small molecules, including aminoglycosides and various synthetic compounds, have been shown to bind RRE SLIIB and competitively inhibit Rev binding, thereby blocking viral replication (ResearchGate, 2001; ASM, 2008).

Other names
Rev response element IIB RNARRE-IIBRRE stem-loop IIBHigh-affinity Rev binding siteRRE SLIIB
02

Mechanism of action

Inhibition of the interaction between the viral Rev protein and the RRE RNA, preventing the nuclear export of unspliced and singly spliced viral mRNA transcripts.

03

Biological functions

Viral mRNA exportNucleocytoplasmic transportViral replicationRNA scaffoldingOther
04

Disease associations

Infection
05

Safety considerations

Potential for off-target binding to human ribosomal RNANephrotoxicity and ototoxicity associated with aminoglycoside bindersRapid emergence of viral resistance through RNA mutations
06

Interacting drugs

Neomycin

3 more in the full profile.

07

Biomarkers

HIV-1 viral loadp24 antigenCD4+ T-cell count

Beyond the preview

Go deeper on HIV-1 Rev response element stem-loop IIB (RRE SLIIB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 Rev response element stem-loop IIB (RRE SLIIB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call